Personalized neuroscience is an emerging interdisciplinary field that intersects neuroscience and personalized medicine, aiming to decipher individual variations in brain structure, function, and connectivity to customize interventions and treatments for diverse neurological and psychiatric conditions. Unlike conventional neuroscience approaches that often generalize findings across populations, personalized neuroscience recognizes the inherent diversity in brain function and treatment responses among individuals. Leveraging cutting-edge technologies such as functional magnetic resonance imaging (fMRI), electroencephalography (EEG), and genetics, researchers can delve deeper into the unique characteristics of each person's brain. A pivotal aspect of personalized neuroscience involves the use of biomarkers—genetic markers, neural activity patterns, and neuroimaging signatures—to characterize brain health and forecast responses to interventions. By pinpointing these biomarkers, clinicians can devise personalized treatment strategies tailored to an individual's distinct neurobiological profile. This approach holds promise across various domains, including mental health, neurodegenerative diseases, and cognitive enhancement. In psychiatry, personalized neuroscience enables optimization of medication selection and dosages based on a patient's neurobiological makeup, potentially minimizing side effects and enhancing treatment outcomes. Likewise, in neurodegenerative disorders like Alzheimer's and Parkinson's, it facilitates early detection and intervention, potentially delaying disease progression. Overall, personalized neuroscience represents a paradigm shift in understanding and addressing neurological and psychiatric conditions, paving the way for more effective, targeted interventions that improve patient outcomes and quality of life.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States